Annual Review of Cancer Biology
 | |
| Discipline | Oncology |
|---|---|
| Language | English |
| Edited by | Laura Attardi, Scott A. Armstrong. |
| Publication details | |
| History | 2017–present, 7 years old |
| Publisher | Annual Reviews (US) |
| Frequency | Annually |
| Subscribe to Open[1] | |
| 4.7[2] (2023) | |
| Standard abbreviations | |
| ISO 4 | Annu. Rev. Cancer Biol. |
| Indexing | |
| ISSN | 2472-3428 |
| OCLC no. | 1097264951 |
| Links | |
The Annual Review of Cancer Biology is a peer-reviewed academic journal that publishes review articles about oncology. It published its first volume in 2017, making it the 47th journal published by the nonprofit Annual Reviews. Founded by Tyler Jacks and Charles L. Sawyers, it is currently edited by Laura Attardi and Scott A. Armstrong.[3] It is content is broadly focused on cancer cell biology, tumorigenesis and cancer progression, and translational cancer science. As of 2020, Annual Review of Cancer Biology has been published open access under the Subscribe to Open (S2O) publishing model.[1][4]
History
The Annual Review of Cancer Biology was first published in 2017, making it the 47th journal title published by Annual Reviews.[5] The stated goals of the journal were to cover the biology of tumor cells, the interaction between the tumor cells and host cells, cancer genomes, drugs for treating cancer, and the resistance of cancer to certain drugs.[6] Each volume has three broad themes: cancer cell biology, tumorigenesis and cancer progression, and translational cancer science.[7] Tyler Jacks and Charles L. Sawyers were the founding editors in 2017.[6] They were succeeded in 2022 by Laura Attardi and Scott A. Armstrong.[3]
As of 2024, Journal Citation Reports lists the journal's impact factor as 4.7, ranking it 73rd of 322 journal titles in the category "Oncology".[2] The journal is not published in print, and is only available electronically.[8] Under Annual Reviews's Subscribe to Open publishing model, the 2020 volume of Annual Review of Cancer Biology was published open access, a first for the journal.[9][10]
Editorial processes
The Annual Review of Cancer Biology is helmed by the editors. The editors are assisted by the editorial committee, which includes associate editors, regular members, and occasionally guest editors. Guest members participate at the invitation of the editors, and serve terms of one year. All other members of the editorial committee are appointed by the Annual Reviews board of directors and serve five-year terms. The editorial committee determines which topics should be included in each volume and solicits reviews from qualified authors.[11] Unsolicited manuscripts are not accepted. Peer review of accepted manuscripts is undertaken by the editorial committee.[12]
References
- ^ a b "Subscribe to Open". Annual Reviews. Retrieved 24 May 2023.
- ^ a b "Journal Impact Factors". Annual Reviews. Retrieved 25 July 2024.
- ^ a b "Annual Review of Cancer Biology Editorial Committee". Annual Reviews. 2022. Retrieved 18 July 2022.
- ^ "Annual Review of Cancer Biology: Aims and Scope of Journal". Annual Reviews. Retrieved 4 April 2023.
- ^ "Annual Review of Cancer Biology – now available online". Annual Reviews. 14 March 2017. Retrieved 14 October 2020.
- ^ a b Jacks, Tyler; Sawyers, Charles (2017). "Introduction". Annual Review of Cancer Biology. 1: i. doi:10.1146/annurev-ca-01-121516-100001.
- ^ "Annual Review of Cancer Biology". Annual Reviews. Retrieved 14 October 2020.
- ^ "Expected Publication Dates". Annual Reviews. Retrieved 14 October 2020.
- ^ "Jisc supports pioneering open access model Subscribe to Open". 10 March 2020. Retrieved 14 October 2020.
- ^ "Annual Review of Cancer Biology". UKSG eNews 465. 9 March 2020. Retrieved 14 October 2020.
- ^ "Editorial Principles and Policies". Annual Reviews. Retrieved 14 October 2020.
- ^ "Information for Unsolicited Authors and Reviewers". Annual Reviews. Retrieved 14 October 2020.